SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-044049
Filing Date
2024-04-12
Accepted
2024-04-12 16:16:30
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A lbph_2024_ann_mtg_notice.htm DEFA14A 19476
2 COURTESY COPY OF LBPH_2024_ANN_MTG_NOTICE lbph-lbph_2024_ann_mtg_notic.pdf DEFA14A 766210
3 GRAPHIC img152495811_0.jpg GRAPHIC 394017
4 GRAPHIC img152495811_1.jpg GRAPHIC 126509
  Complete submission text file 0000950170-24-044049.txt   1793014
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40192 | Film No.: 24841691
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)